Vinay Bhupathy

Sheppard Mullin (Century City)
Associate

Vinay Bhupathy is a member of the firm’s healthcare practice team and an associate in the Corporate Practice Group in the firm’s Century city office. Vinay’s health care practice bridges the gap between regulatory and transaction law and he represents all manner of healthcare entities from providers such as hospitals and physician groups to payors and health information technology companies.From a regulatory perspective, Vinay is able to provide comprehensive counseling to healthcare clients with his experience in a broad range of areas including shared savings and reimbursement issues, data security and privacy, fraud and abuse laws, corporate practice of medicine and FDA medical device regulation. He regularly assists providers with navigating the complex issues surrounding CMS innovation models such as the Medicare Shared Savings Program and the Bundled Payments for Care Improvement Initiative. Vinay also assists medical device and health care technology companies - especially health information technology companies and mobile app developers - with FDA-regulation compliance throughout the product life cycle, from product development to post-market compliance. His practice extends to contract drafting and negotiation for managed care companies, insurers, hospitals, health systems, physicians, and ancillary providers. In addition to his regulatory experience, Vinay also advises clients in connection with corporate issues surrounding complex joint ventures between health care entities. He also has experience negotiating mergers and advising clients on professional services, management services and health information technology license agreements. Vinay regularly advises clients on formation, corporate governance and operational matters for various healthcare entities.

Linked authors

Sheppard Mullin (Los Angeles)
Sheppard Mullin (Century City)

Articles

81 Bulletin

David R. Garcia, Helen Cho Eckert, Vinay Bhupathy The FTC expresses “strong concerns” over State regulations offering to provide antitrust immunity to certain healthcare collaborations undertaken with Department of health’s approval and supervision (COPA)

81

State Regulatory Scheme Offering Antitrust Immunity to Healthcare Collaborations Creates Tension Between Federal and State Antitrust Enforcement* On April 22, 2015, the Federal Trade Commission submitted a public letter to the New York State Department of Health (DOH) expressing “strong (...)

Send a message